{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T10:43:27Z","timestamp":1776681807612,"version":"3.51.2"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T00:00:00Z","timestamp":1201737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s11938-008-0008-8","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T14:40:23Z","timestamp":1201704023000},"page":"64-69","source":"Crossref","is-referenced-by-count":23,"title":["Esophageal disease in progressive systemic sclerosis"],"prefix":"10.1007","volume":"11","author":[{"given":"Ellen C.","family":"Ebert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,31]]},"reference":[{"key":"8_CR1","first-page":"202","volume":"15","author":"E.C. LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischemajer R, et al.: Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988, 15:202\u2013205.","journal-title":"J Rheumatol"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.mcg.0000225549.19127.90","volume":"40","author":"E.C. Ebert","year":"2006","unstructured":"Ebert EC: Esophageal disease in scleroderma. J Clin Gastroenterol 2006, 40:769\u2013775.","journal-title":"J Clin Gastroenterol"},{"key":"8_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/0003-4819-59-3-351","volume":"59","author":"W.L. Treacy","year":"1963","unstructured":"Treacy WL, Baggenstoss AH, Slocumb CH, Code CF: Scleroderma of the esophagus. A correlation of histologic and physiologic findings. Ann Intern Med 1963, 59:351\u2013356.","journal-title":"Ann Intern Med"},{"key":"8_CR4","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1172\/JCI107084","volume":"51","author":"S. Cohen","year":"1972","unstructured":"Cohen S, Fisher R, Lipshutz W, et al.: The pathogenesis of esophageal dysfunction in scleroderma and Raynaud\u2019s disease. J Clin Invest 1972, 51:2663\u20132668.","journal-title":"J Clin Invest"},{"key":"8_CR5","first-page":"52","volume":"92","author":"H. El-Serag","year":"1997","unstructured":"El-Serag H, Sonnenberg A: Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 1997, 92:52\u201356.","journal-title":"Am J Gastroenterol"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0016-5085(85)90440-8","volume":"89","author":"M.C. Segel","year":"1985","unstructured":"Segel MC, Campbell WL, Medsger TA, Roumm AD: Systemic sclerosis and esophageal adenocarcinoma: is increased patient screening necessary? Gastroenterology 1985, 89:486\u2013488.","journal-title":"Gastroenterology"},{"key":"8_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0016-5085(87)90137-5","volume":"92","author":"B.J. Zamost","year":"1987","unstructured":"Zamost BJ, Hirschberg J, Ippoliti AF, et al.: Esophagitis in scleroderma: prevalence and risk factors. Gastroenterology 1987, 92:421\u2013428.","journal-title":"Gastroenterology"},{"key":"8_CR8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1023\/A:1018847126143","volume":"42","author":"E.C. Ebert","year":"1997","unstructured":"Ebert EC, Ruggiero FM, Seibold JR: Intestinal perforation: a common complication of scleroderma. Dig Dis Sci 1997, 42:549\u2013553.","journal-title":"Dig Dis Sci"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/BF02090373","volume":"39","author":"M. Wegener","year":"1994","unstructured":"Wegener M, Adamek RJ, Wedmann B, et al.: Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 1994, 39:2209\u20132215.","journal-title":"Dig Dis Sci"},{"key":"8_CR10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/0016-5085(84)90089-1","volume":"87","author":"G.J. Maddern","year":"1984","unstructured":"Maddern GJ, Horowitz M, Jamieson CG, et al.: Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology 1984, 87:922\u2013926.","journal-title":"Gastroenterology"},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archinte.1976.03630050063011","volume":"136","author":"A.K. Mukhopadhyay","year":"1976","unstructured":"Mukhopadhyay AK, Graham DY: Esophageal motor dysfunction in systemic diseases. Arch Intern Med 1976, 136:583\u2013587.","journal-title":"Arch Intern Med"},{"key":"8_CR12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archinte.1989.00390030075014","volume":"149","author":"D.A. Johnson","year":"1989","unstructured":"Johnson DA, Drane WE, Curran J, et al.: Pulmonary disease in progressive systemic sclerosis: a complication of gastroesophageal reflux and occult aspiration? Arch Intern Med 1989, 149:589\u2013593.","journal-title":"Arch Intern Med"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF02208346","volume":"14","author":"A. Olive","year":"1995","unstructured":"Olive A, Juncosa S, Evison G, et al.: Air in the oesophagus: a sign of oesophageal involvement in systemic sclerosis. Clin Rheumatol 1995, 14:319\u2013321.","journal-title":"Clin Rheumatol"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/BF01333709","volume":"24","author":"P.J. Clements","year":"1979","unstructured":"Clements PJ, Kadell B, Ippoliti A, Ross M: Esophageal motility in progressive systemic sclerosis: comparison of cine-radiographic and manometric evaluation. Dig Dis Sci 1979, 24:639\u2013644.","journal-title":"Dig Dis Sci"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0016-5085(92)91713-E","volume":"102","author":"H.A. Klein","year":"1992","unstructured":"Klein HA, Wald A, Graham TO, et al.: Comparative studies of esophageal function in systemic sclerosis. Gastroenterology 1992, 102:1551\u20131556.","journal-title":"Gastroenterology"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/BF01300380","volume":"37","author":"J.R. Murphy","year":"1992","unstructured":"Murphy JR, McNally P, Peller P, et al.: Prolonged clearance is the primary abnormal reflux parameter in patients with progressive sclerosis and esophagitis. Dig Dis Sci 1992, 37:833\u2013841.","journal-title":"Dig Dis Sci"},{"key":"8_CR17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/00365528708991497","volume":"22","author":"P. Stentoft","year":"1987","unstructured":"Stentoft P, Hendel L, Aggestrup S: Esophageal manometry and pH-probe monitoring in the evaluation of gastroesophageal reflux in patients with progressive systemic sclerosis. Scand J Gastroenterol 1987, 22:499\u2013504.","journal-title":"Scand J Gastroenterol"},{"key":"8_CR18","first-page":"2692","volume":"27","author":"P. Weber","year":"2000","unstructured":"Weber P, Ganser G, Frosch M, et al.: Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease. J Rheumatol 2000, 27:2692\u20132695.","journal-title":"J Rheumatol"},{"key":"8_CR19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0003-4975(10)63972-0","volume":"22","author":"M.B. Orringer","year":"1976","unstructured":"Orringer MB, Dabich L, Zarafonetis CJ, et al.: Gastroesophageal reflux in esophageal scleroderma: diagnosis and implications. Ann Thorac Surg 1976, 22:120\u2013130.","journal-title":"Ann Thorac Surg"},{"key":"8_CR20","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1023\/A:1026656220075","volume":"44","author":"F. Carola","year":"1999","unstructured":"Carola F, Bianchi PA, Basilisco G: Intraesophageal pH monitoring during acid infusion in patients with systemic sclerosis. Dig Dis Sci 1999, 44:1716\u20131720.","journal-title":"Dig Dis Sci"},{"key":"8_CR21","first-page":"1837","volume":"18","author":"M. Baron","year":"1991","unstructured":"Baron M, Arzoumanian A: Radionuclide esophageal transit studies in progressive systemic sclerosis: an analysis of longitudinal data. J Rheumatol 1991, 18:1837\u20131840.","journal-title":"J Rheumatol"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/03009748709102931","volume":"16","author":"A. Akesson","year":"1987","unstructured":"Akesson A, Gustafson T, Wollheim F, et al.: Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis. Scand J Rheumatol 1987, 16:291\u2013299.","journal-title":"Scand J Rheumatol"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1023\/A:1018831104549","volume":"42","author":"G.E. Villadsen","year":"1997","unstructured":"Villadsen GE, Storkholm JH, Hendel L, et al.: Impedance planimetric characterization of esophagus in systemic sclerosis patients with severe involvement of esophagus. Dig Dis Sci 1997, 42:2317\u20132326.","journal-title":"Dig Dis Sci"},{"key":"8_CR24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1572-0241.2004.30035.x","volume":"99","author":"R. Tutuian","year":"2004","unstructured":"Tutuian R, Castell DO: Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol 2004, 99:1011\u20131019.","journal-title":"Am J Gastroenterol"},{"key":"8_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0016-5085(93)90007-Y","volume":"105","author":"L.S. Miller","year":"1993","unstructured":"Miller LS, Liu JB, Klenn PJ, et al.: Endoluminal ultrasonography of the distal esophagus in systemic sclerosis. Gastroenterology 1993, 105:31\u201339.","journal-title":"Gastroenterology"},{"key":"8_CR26","first-page":"763","volume":"92","author":"G. Lock","year":"1997","unstructured":"Lock G, Holstegee A, Lang B, et al.: Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 1997, 92:763\u2013771.","journal-title":"Am J Gastroenterol"},{"key":"8_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002960050010","volume":"17","author":"G. Lock","year":"1997","unstructured":"Lock G, Zeuner M, Straub RH, et al.: Esophageal manometry in systemic sclerosis: screening procedure or confined to symptomatic patients? Rheumatol Int 1997, 17:61\u201366.","journal-title":"Rheumatol Int"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2036.2006.02804.x","volume":"23","author":"H. Sallam","year":"2006","unstructured":"Sallam H, McNearney TA, Chen JD: Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis. Aliment Pharmacol Ther 2006, 23:691\u2013712.","journal-title":"Aliment Pharmacol Ther"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1378\/chest.106.3.738","volume":"106","author":"J.P. Shoenut","year":"1994","unstructured":"Shoenut JP, Kerr P, Micflikier AB, et al.: The effect of nasal CPAP on nocturnal reflux in patients with aperistaltic esophagus. Chest 1994, 106:738\u2013741.","journal-title":"Chest"},{"key":"8_CR30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/art.1780280504","volume":"28","author":"A. Kahan","year":"1985","unstructured":"Kahan A, Bour B, Couturier D, et al.: Nifedipine and esophageal dysfunction in progressive systemic sclerosis. A controlled manometric study. Arthritis Rheum 1985, 28:490\u2013495.","journal-title":"Arthritis Rheum"},{"key":"8_CR31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/art.1780290821","volume":"29","author":"F. Jean","year":"1986","unstructured":"Jean F, Aubert A, Bloch F, et al.: Effects of diltiazem versus nifedipine on lower esophageal sphincter pressure in patients with progressive systemic sclerosis. Arthritis Rheum 1986, 29:1054\u20131055.","journal-title":"Arthritis Rheum"},{"key":"8_CR32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/00365528609011120","volume":"21","author":"L. Hendel","year":"1986","unstructured":"Hendel L, Aggestrup S, Stentoft P: Long-term ranitidine in progressive systemic sclerosis (scleroderma) with gastroesophageal reflux. Scand J Gastroenterol 1986, 21:799\u2013805.","journal-title":"Scand J Gastroenterol"},{"key":"8_CR33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0016-5085(79)90223-3","volume":"77","author":"R.J. Petrokubi","year":"1979","unstructured":"Petrokubi RJ, Jeffries GH: Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study. Gastroenterology 1979, 77:691\u2013695.","journal-title":"Gastroenterology"},{"key":"8_CR34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2036.1992.tb00571.x","volume":"6","author":"L. Hendel","year":"1992","unstructured":"Hendel L, Hage E, Hendel J, Stentoft P: Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther 1992, 6:565\u2013577.","journal-title":"Aliment Pharmacol Ther"},{"key":"8_CR35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00042737-200307000-00010","volume":"15","author":"E. Hage","year":"2003","unstructured":"Hage E, Hendel L, Gustafsen J, Hendel J: Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole. Eur J Gastroenterol Hepatol 2003, 15:781\u2013789.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"8_CR36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2036.1991.tb00516.x","volume":"5","author":"L. Hendel","year":"1991","unstructured":"Hendel L: Hydroxyproline in the oesophageal mucosa of patients with progressive systemic sclerosis during omeprazole-induced healing of reflux oesophagitis. Aliment Pharmacol Ther 1991, 5:471\u2013480.","journal-title":"Aliment Pharmacol Ther"},{"key":"8_CR37","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archinte.1987.00370090075014","volume":"147","author":"D.A. Johnson","year":"1987","unstructured":"Johnson DA, Drane WE, Curran J, et al.: Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities. Arch Intern Med 1987, 147:1597\u20131601.","journal-title":"Arch Intern Med"},{"key":"8_CR38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/art.1780200105","volume":"20","author":"M. Ramirez-Mata","year":"1977","unstructured":"Ramirez-Mata M, Ibanez G, Alarcon-Segovia D: Stimulatory effect of metoclopramide on the esophagus and lower esophageal sphincter of patients with PSS. Arthritis Rheum 1977, 20:30.","journal-title":"Arthritis Rheum"},{"key":"8_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s100670200010","volume":"21","author":"S.J. Wang","year":"2002","unstructured":"Wang SJ, La JL, Chen DY, et al.: Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis. Clin Rheumatol 2002, 21:43\u201345.","journal-title":"Clin Rheumatol"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2125.1991.tb05593.x","volume":"31","author":"A. Kahan","year":"1991","unstructured":"Kahan A, Chaussade S, Gaudric M, et al.: The effect of cisapride on gastro-oesophageal dysfunction in systemic sclerosis: a controlled manometric study. Br J Clin Pharmacol 1991, 31:683\u2013687.","journal-title":"Br J Clin Pharmacol"},{"key":"8_CR41","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3109\/00365528708991971","volume":"22","author":"B. Kaada","year":"1987","unstructured":"Kaada B: Successful treatment of esophageal dysmotility and Raynaud\u2019s phenomenon in systemic sclerosis and achalasia by transcutaneous nerve stimulation. Increase in plasma VIP concentration. Scand J Gastroenterol 1987, 22:1137\u20131146.","journal-title":"Scand J Gastroenterol"},{"key":"8_CR42","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3109\/00365529008997628","volume":"25","author":"F. Mearin","year":"1990","unstructured":"Mearin F, Zacchi P, Armengol JR, et al.: Effect of transcutaneous nerve stimulation on esophageal motility in patients with achalasia and scleroderma. Scand J Gastroenterol 1990, 25:1018\u20131023.","journal-title":"Scand J Gastroenterol"},{"key":"8_CR43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1346-8138.1988.tb03665.x","volume":"15","author":"M. Maeda","year":"1988","unstructured":"Maeda M, Ichiki Y, Sumi A, Mori S: A trial of acupuncture for progressive systemic sclerosis. J Dermatol 1988, 15:133\u2013140.","journal-title":"J Dermatol"},{"key":"8_CR44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0002-9343(92)90043-B","volume":"93","author":"P.H. Dessein","year":"1992","unstructured":"Dessein PH, Joffe BI, Metz RM, et al.: Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 1992, 93:143\u2013150.","journal-title":"Am J Med"},{"key":"8_CR45","first-page":"624","volume":"90","author":"M.B. Orringer","year":"1981","unstructured":"Orringer MB, Orringer JS, Dabich L, Zarafonetis CJ: Combined Collis gastroplasty-fundoplication operations for scleroderma reflux esophagitis. Surgery 1981, 90:624\u2013630.","journal-title":"Surgery"},{"key":"8_CR46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0003-4975(94)91073-1","volume":"58","author":"N.C. Poirier","year":"1994","unstructured":"Poirier NC, Taillefer R, Topart P, Duranceau A: Antireflux operations in patients with scleroderma. Ann Thorac Surg 1994, 58:66\u201372; discussion 72\u201373.","journal-title":"Ann Thorac Surg"},{"key":"8_CR47","first-page":"131","volume":"41","author":"J.P. O\u2019Leary","year":"1975","unstructured":"O\u2019Leary JP, Hollenbeck JI, Woodward ER: Surgical treatment of esophageal stricture in patients with scleroderma. Am Surg 1975, 41:131\u2013135.","journal-title":"Am Surg"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-008-0008-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-008-0008-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-008-0008-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:37Z","timestamp":1559436997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-008-0008-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,31]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s11938-008-0008-8","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,31]]}}}